The optimism lasted exactly one month. In February, the Massachusetts Business Confidence Index had crossed the line separating pessimism from optimism for the first time in a year—a small but significant respite for the state’s employers after months of mounting uncertainty. In March, that relief vanished. The AIM Business Confidence Index, the longest-running barometer of […]
Cambridge-based Biogen announced it will acquire Apellis Pharmaceuticals, headquartered in Waltham, in an all-cash deal worth approximately $5.6 billion — or $41 per share. When Apellis stock closed on Monday, it was trading at roughly half that. By Tuesday morning, shares had more than doubled overnight. That kind of move tells you something about what
Something unexpected happened in the middle of 2025. While the Trump administration was cutting $27 billion from federal rental assistance programs and proposing the elimination of the Department of Housing and Urban Development as most people know it, Congress quietly did something that developers of affordable housing had been waiting years for: it made the
The Federal Tax Credit That’s Sending Boston Developers Back to the Drawing Board Read More »
Wall Street opened Monday on shaky ground as investors scrambled to reassess their portfolios in response to a new wave of conflict in the Middle East involving Iran. The market reaction was swift and telling: energy companies surged, defense contractors rallied, while airlines, cruise operators, and luxury brands took a sharp hit. Brent crude oil
Global Markets Rattled as Iran Conflict Sends Energy and Defense Stocks Soaring Read More »
